Skip to content

Welcome to our new website

87 Antibody2c immunoglobulins2c 3d rendering web

Mabtech divested to IK Investment Partners

Divestment to IK Partners
November 2019
Sector: Healthcare
Service: M&A

Our role

Exclusive financial adviser to the owners of Mabtech on the sale to IK Partners


IK Partners is Pan-European private equity firm focused on investments in the Nordics, DACH region, France and Benelux. Since 1989, IK Partners has raised more than EUR 10 billion of capital and invested in over 125 European companies. In connection with the transaction, Merieux Equity Partners acquired a minority stake alongside IK Partners' fund


Mabtech was founded in 1986 and has gained worldwide recognition for its high quality monoclonal antibodies and technical capabilities and is viewed as a pioneer within the growing detection platform techniques ELISpot and FluoroSpot